Blackmon, Karen http://orcid.org/0000-0002-2665-7807
Day, Gregory S.
Powers, Harry Ross
Bosch, Wendelyn
Prabhakaran, Divya
Woolston, Dixie
Pedraza, Otto
Funding for this research was provided by:
Donald and Lucy Dayton Professorship
Article History
Received: 29 November 2021
Accepted: 23 July 2022
First Online: 30 July 2022
Declarations
:
: Study procedures were approved by the Institutional Review Board at Mayo Clinic (IRB# 20–005424) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all participants electronically. There was no financial compensation for participation in the study.
: Not applicable.
: GSD owns stock (> $10,000) in ANI Pharmaceuticals (a generic pharmaceutical company). He serves as a topic editor for DynaMed (EBSCO), overseeing development of evidence-based educational content, a consultant for Parabon Nanolabs (advice relevant to NIH small business grant submission), and as the Clinical Director of the Anti-NMDA Receptor Encephalitis Foundation, Inc, Canada (uncompensated). None of the other authors have conflicts of interest to disclose.